Description: This article summarizes a recent session at an SOA meeting that presented tips on improving and speeding the product filing process.

Description: A discussion about regulators, lawmakers, actuaries and insurers working together to keep health insurance costs affordable to the consumer but also profitable enough for insurers to continue to offer the product.

Description: The diary of Dirk Nieder, an actuary who traveled in Asia amid the COVID-19 pandemic, tying in what he saw in asia countries and developments from the west.

Description: Article examines a proposed amendment to the MAP-21 Act that would have changed a number of tax requirements regarding so-called life settlements.

Description: Adding value in the development, production and marketing process of medical devises regulatory environment, designer/manufacturer perspective, product failure and litigation risk. Issue No. 44.

Description: This article provides information on the 2025 SOA Health Meeting, including how to submit a proposal, key dates, and other relevant information.

Description: The coming wave of biosimilars could have a major impact on prescription drug spend in coming years. The big event of Humira biosimilar launches in 2023 will be significant in determining that ultimate impact. Payers are making coverage decisions. The more biosimilars are utilized, the greater the potential savings. How will biosimilar adoption be maximized?

Description: Chris Smith, vice chair of the Actuary of the Future section, had the privilege of attending the SOA Health meeting in Seattle for the first time this year. Read about his experience and thoughts on why you should plan to attend an SOA-sponsored conference for your career growth.

Description: A brief review of the 2024 SOA Health Meeting in Baltimore

Description: This paper is a primer for actuaries with limited experience in accessing and using public data sets. From Small Talk Newsletter, November 2005, Issue No. 25.